CELJF — Cellcom Israel Balance Sheet
0.000.00%
- $1.71bn
- $2.36bn
- ILS4.44bn
- 92
- 73
- 84
- 97
Annual balance sheet for Cellcom Israel, fiscal year end - December 31st, ILS millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 6-K | ARS | ARS | ARS | ARS |
| Standards: | — | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,148 | 667 | 916 | 497 | 396 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,024 | 936 | 880 | 920 | 891 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,299 | 1,800 | 2,012 | 1,635 | 1,558 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2,041 | 2,012 | 2,145 | 2,153 | 2,154 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 7,157 | 6,570 | 6,998 | 6,620 | 6,504 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,929 | 1,710 | 1,924 | 1,981 | 2,083 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 5,277 | 4,649 | 4,894 | 4,357 | 4,052 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 1,880 | 1,921 | 2,104 | 2,263 | 2,452 |
| Total Liabilities & Shareholders' Equity | 7,157 | 6,570 | 6,998 | 6,620 | 6,504 |
| Total Common Shares Outstanding |